Press Releases
Washington, D.C. (April 7, 2021)—On Thursday, April 15, 2021, at 10:00 a.m. ET, Rep. James E. Clyburn, the Chairman of the Select Subcommittee on the Coronavirus Crisis, will hold a hybrid in-person / remote hearing with Centers for Disease Control and Prevention Director Rochelle P. Walensky, National Institute of Allergy and Infectious Diseases Director Anthony S. Fauci, and Chief Science Officer for COVID Response David Kessler.
Washington, D.C. (Apr. 6, 2021)—Today, Rep. Raja Krishnamoorthi, the Chairman of the Subcommittee on Economic and Consumer Policy, sent a letter to YouTube requesting documents and information about the YouTube Kids platform amid concerns about content quality, advertisement practices, and the impact on children.
Washington, D.C. (Apr. 6, 2021)—Rep. Gerald E. Connolly, Chairman of the Subcommittee on Government Operations, and Rep. Jody B. Hice, Ranking Member of the Subcommittee on Government Operations, sent a letter to President Joseph R. Biden requesting that he prioritize nominations to the Merit Systems Protection Board (MSPB).
Washington D.C. – Today, Reps. Adam Schiff (D-CA) and Carolyn B. Maloney (D-NY), along with Reps. Barbara Lee (D-CA), Mike Quigley (D-IL), Katherine Clark (D-MA), Jamie Raskin (D-MD), Alexandria Ocasio-Cortez (D-NY), Chris Pappas (D-NH), and Ritchie Torres (D-NY) introduced a resolution highlighting the urgent need for nondiscriminatory and equitable blood and blood product donation policies in the United States.
| Washington, D.C. (Apr. 1, 2021)—Today, Rep. Carolyn B. Maloney, the Chairwoman of the Committee on Oversight and Reform, issued this statement following release of the Office of National Drug Control Policy's (ONDCP) Drug Control Policy Statement: "I am pleased to see the Biden-Harris Administration's ONDCP meet its first benchmark in the timely release of the required Drug Control Policy Statement, especially after the failures of the last administration.
|
WASHINGTON, D.C. — The U.S. Government Accountability Office (GAO) released a new report reviewing the government funding that led to the development of the drug Remdesivir, which costs $3,120 for a five day course of treatment.
Washington, D.C. (Mar. 31, 2021)—On Wednesday, April 14, 2021, at 10:00 a.m., Rep. Carolyn B. Maloney, the Chairwoman of the Committee on Oversight and Reform, along with Committee Member Congresswoman Eleanor Holmes Norton, will hold a business meeting on H.R. 51, the Washington, D.C. Admission Act, introduced by Congresswoman Norton on January 4, 2021.
Washington D.C. (March 31, 2021)—Chairman James E. Clyburn and all Democratic Members of the Select Subcommittee on the Coronavirus Crisis sent letters to the Department of Health and Human Services, the Department of Homeland Security, the Federal Emergency Management Agency, and the National Archives as part of an ongoing investigation into the Trump Administration's efforts to procure and distribute personal protective equipment (PPE) and other critical supplies during the pandemic. The Select Subcommittee also released new documents obtained in this investigation.
Washington, D.C. (March 25, 2021)—Today, Committee and Subcommittee Chairs across the House of Representatives sent letters to the White House, federal agencies, law enforcement, and Legislative Branch entities, including the House and Senate Sergeant at Arms, seeking documents and communications relating to the January 6, 2021, domestic terrorist assault on the Capitol.